| Funding Opportunity |
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 23 035
Funding Number: RFA CA 23 035
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 23 003
Funding Number: RFA CA 23 003
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed) Apply for RFA CA 22 056
Funding Number: RFA CA 22 056
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional) Apply for RFA MH 22 130
Funding Number: RFA MH 22 130
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) Apply for RFA DA 22 001
Funding Number: RFA DA 22 001
Agency: National Institutes of Health
Funding Amount: Case Dependent |
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 19 146
Funding Number: PAR 19 146
Agency: National Institutes of Health
Funding Amount: $200,000 |
International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) Apply for PA 18 773
Funding Number: PA 18 773
Agency: National Institutes of Health
Funding Amount: Case Dependent |
International Tobacco, and Health Research and Capacity Building Program (R01) Apply for RFA TW 16 003
Funding Number: RFA TW 16 003
Agency: National Institutes of Health
Funding Amount: $250,000 |
Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24) Apply for RFA CA 16 502
Funding Number: RFA CA 16 502
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $300,000 |
U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21) Apply for RFA CA 16 015
Funding Number: RFA CA 16 015
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $100,000 |
Cancer Target Discovery and Development Network (U01) Apply for RFA CA 16 014
Funding Number: RFA CA 16 014
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $750,000 |
U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01) Apply for RFA AA 17 006
Funding Number: RFA AA 17 006
Agency: Department of Health and Human Services, National Institutes of Health
Funding Amount: $200,000 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01) Apply for PAR 16 338
Funding Number: PAR 16 338
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21) Apply for PAR 16 336
Funding Number: PAR 16 336
Agency: HHS-NIH11
Funding Amount: $200,000 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03) Apply for PAR 16 337
Funding Number: PAR 16 337
Agency: HHS-NIH11
Funding Amount: $50,000 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21) Apply for PAR 16 318
Funding Number: PAR 16 318
Agency: HHS-NIH11
Funding Amount: $200,000 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01) Apply for PAR 16 317
Funding Number: PAR 16 317
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24) Apply for RFA AA 17 004
Funding Number: RFA AA 17 004
Agency: HHS-NIH11
Funding Amount: $350,000 |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24) Apply for RFA AA 17 005
Funding Number: RFA AA 17 005
Agency: HHS-NIH11
Funding Amount: $600,000 |
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01) Apply for RFA AA 17 003
Funding Number: RFA AA 17 003
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Integrative Research on Polysubstance Abuse and Addiction (R21/R33) Apply for PAR 16 291
Funding Number: PAR 16 291
Agency: HHS-NIH11
Funding Amount: $200,000 |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) Apply for PAR 16 292
Funding Number: PAR 16 292
Agency: HHS-NIH11
Funding Amount: $125,000 |
The NCI Transition Career Development Award (K22) Apply for PAR 16 293
Funding Number: PAR 16 293
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Silencing of HIV-1 Proviruses (R61/R33) Apply for RFA AI 16 038
Funding Number: RFA AI 16 038
Agency: HHS-NIH11
Funding Amount: $500,000 |
Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) Apply for PAR 16 284
Funding Number: PAR 16 284
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R21) Apply for PAR 16 277
Funding Number: PAR 16 277
Agency: HHS-NIH11
Funding Amount: $200,000 |
Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71) Apply for PAR 16 281
Funding Number: PAR 16 281
Agency: HHS-NIH11
Funding Amount: $28,000 |
Prescription Drug Abuse (R21) Apply for PA 16 232
Funding Number: PA 16 232
Agency: HHS-NIH11
Funding Amount: $200,000 |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21) Apply for PAR 16 278
Funding Number: PAR 16 278
Agency: HHS-NIH11
Funding Amount: $200,000 |
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11) Apply for PAR 16 280
Funding Number: PAR 16 280
Agency: HHS-NIH11
Funding Amount: $92,000 |
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43) Apply for PAR 16 279
Funding Number: PAR 16 279
Agency: HHS-NIH11
Funding Amount: $280,000 |
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01) Apply for PAR 16 276
Funding Number: PAR 16 276
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Serious Adverse Drug Reaction Research (R01) Apply for PAR 16 275
Funding Number: PAR 16 275
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Serious Adverse Drug Reaction Research (R21) Apply for PAR 16 274
Funding Number: PAR 16 274
Agency: HHS-NIH11
Funding Amount: $200,000 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01) Apply for PAR 16 266
Funding Number: PAR 16 266
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Methodology and Measurement in the Behavioral and Social Sciences (R21) Apply for PAR 16 261
Funding Number: PAR 16 261
Agency: HHS-NIH11
Funding Amount: $200,000 |
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Apply for PA 16 258
Funding Number: PA 16 258
Agency: HHS-NIH11
Funding Amount: $200,000 |
Methodology and Measurement in the Behavioral and Social Sciences (R01) Apply for PAR 16 260
Funding Number: PAR 16 260
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer-related Behavioral Research through Integrating Existing Data (R01) Apply for PAR 16 256
Funding Number: PAR 16 256
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer-related Behavioral Research through Integrating Existing Data (R21) Apply for PAR 16 255
Funding Number: PAR 16 255
Agency: HHS-NIH11
Funding Amount: $200,000 |
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21) Apply for PAR 16 257
Funding Number: PAR 16 257
Agency: HHS-NIH11
Funding Amount: $200,000 |
Building Evidence: Effective Palliative/End of Life Care Interventions (R01) Apply for PAR 16 250
Funding Number: PAR 16 250
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01) Apply for PAR 16 234
Funding Number: PAR 16 234
Agency: HHS-NIH11
Funding Amount: $500,000 |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21) Apply for PAR 16 248
Funding Number: PAR 16 248
Agency: HHS-NIH11
Funding Amount: $200,000 |
Gene Fusions in Pediatric Sarcomas (R21) Apply for PA 16 252
Funding Number: PA 16 252
Agency: HHS-NIH11
Funding Amount: $200,000 |
Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01) Apply for PAR 16 249
Funding Number: PAR 16 249
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Gene Fusions in Pediatric Sarcomas (R01) Apply for PA 16 251
Funding Number: PA 16 251
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Prescription Drug Abuse (R01) Apply for PA 16 233
Funding Number: PA 16 233
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Neural Regulation of Cancer (R21) Apply for PAR 16 246
Funding Number: PAR 16 246
Agency: HHS-NIH11
Funding Amount: $200,000 |
Neural Regulation of Cancer (R01) Apply for PAR 16 245
Funding Number: PAR 16 245
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites (U01) Apply for RFA HG 16 010
Funding Number: RFA HG 16 010
Agency: HHS-NIH11
Funding Amount: $2,000,000 |
Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity (U01) Apply for RFA HG 16 011
Funding Number: RFA HG 16 011
Agency: HHS-NIH11
Funding Amount: $2,500,000 |
Metabolic Reprogramming to Improve Immunotherapy (R01) Apply for PAR 16 228
Funding Number: PAR 16 228
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Non-healing Ulcerative Wounds in Aging (R01) Apply for PA 16 230
Funding Number: PA 16 230
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Metabolic Reprogramming to Improve Immunotherapy (R21) Apply for PAR 16 229
Funding Number: PAR 16 229
Agency: HHS-NIH11
Funding Amount: $200,000 |
The Role of Mobile Genetic Elements in Cancer (R01) Apply for PAR 16 227
Funding Number: PAR 16 227
Agency: HHS-NIH11
Funding Amount: Case Dependent |
NIDA Research Education Program for Clinical Researchers and Clinicians (R25) Apply for PAR 16 224
Funding Number: PAR 16 224
Agency: HHS-NIH11
Funding Amount: $350,000 |
The Role of Mobile Genetic Elements in Cancer (R21) Apply for PAR 16 226
Funding Number: PAR 16 226
Agency: HHS-NIH11
Funding Amount: $200,000 |
Health Services Research on Minority Health and Health Disparities (R01) Apply for PAR 16 221
Funding Number: PAR 16 221
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Health Services Research on Minority Health and Health Disparities (R21) Apply for PAR 16 222
Funding Number: PAR 16 222
Agency: HHS-NIH11
Funding Amount: $200,000 |
Research Answers to NCIs Pediatric Provocative Questions (R01) Apply for PAR 16 218
Funding Number: PAR 16 218
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Research Answers to NCIs Pediatric Provocative Questions (R21) Apply for PAR 16 217
Funding Number: PAR 16 217
Agency: HHS-NIH11
Funding Amount: $200,000 |
Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research (R41/R42) Apply for RFA DA 17 008
Funding Number: RFA DA 17 008
Agency: HHS-NIH11
Funding Amount: $150,000 |
Extracellular Vesicle Tools, Technologies, and Products for Neuroscience Research (R43/R44) Apply for RFA DA 17 009
Funding Number: RFA DA 17 009
Agency: HHS-NIH11
Funding Amount: $150,000 |
Leveraging Cognitive Neuroscience Research to Improve Assessment of Cancer Treatment Related Cognitive Impairment (R01) Apply for PAR 16 212
Funding Number: PAR 16 212
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21) Apply for PAR 16 213
Funding Number: PAR 16 213
Agency: HHS-NIH11
Funding Amount: $200,000 |
NLM Career Development Award in Biomedical Informatics and Data Science (K01) Apply for PAR 16 204
Funding Number: PAR 16 204
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (R25) Apply for RFA DA 17 007
Funding Number: RFA DA 17 007
Agency: HHS-NIH11
Funding Amount: $250,000 |
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21) Apply for PAR 16 201
Funding Number: PAR 16 201
Agency: HHS-NIH11
Funding Amount: $200,000 |
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01) Apply for PAR 16 202
Funding Number: PAR 16 202
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Laboratory and Diagnostic Tools to Advance Microbiome-Brain Research (R41) Apply for RFA DA 17 016
Funding Number: RFA DA 17 016
Agency: HHS-NIH11
Funding Amount: $150,000 |
Laboratory and Diagnostic Tools to Advance Microbiome-Brain Research (R43/R44) Apply for RFA DA 17 017
Funding Number: RFA DA 17 017
Agency: HHS-NIH11
Funding Amount: $150,000 |
Tools for Cell Line Identification (R43/R44) Apply for PA 16 186
Funding Number: PA 16 186
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Paul Calabresi Career Development Award for Clinical Oncology (K12) Apply for PAR 16 189
Funding Number: PAR 16 189
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Improved Technologies and Ligands for Non-invasive Brain Imaging (R41/R42) Apply for RFA DA 17 010
Funding Number: RFA DA 17 010
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Improved Technologies and Ligands for Non-invasive Brain Imaging (R43/R44) Apply for RFA DA 17 011
Funding Number: RFA DA 17 011
Agency: HHS-NIH11
Funding Amount: Case Dependent |
NCI Clinical and Translational Exploratory/Developmental Studies (R21) Apply for PAR 16 176
Funding Number: PAR 16 176
Agency: HHS-NIH11
Funding Amount: $200,000 |
Exploratory Grants in Cancer Epidemiology and Genomics Research (R21) Apply for PA 16 175
Funding Number: PA 16 175
Agency: HHS-NIH11
Funding Amount: $200,000 |
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) Apply for PA 16 177
Funding Number: PA 16 177
Agency: HHS-NIH11
Funding Amount: $200,000 |
Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R21) Apply for RFA MH 17 100
Funding Number: RFA MH 17 100
Agency: HHS-NIH11
Funding Amount: $200,000 |
Novel Strategies for Targeting HIV-CNS Reservoirs without Reactivation (R01) Apply for RFA MH 17 101
Funding Number: RFA MH 17 101
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Integrating Biospecimen Science into Clinical Assay Development (U01) Apply for PAR 16 166
Funding Number: PAR 16 166
Agency: HHS-NIH11
Funding Amount: $250,000 |
Revision Applications to U01 Awards for Research on the NCI's Provocative Questions (U01) Apply for RFA CA 16 011
Funding Number: RFA CA 16 011
Agency: HHS-NIH11
Funding Amount: $150,000 |
Revisions Applications to P50 Awards for Research on NCI's Provocative Questions (P50) Apply for RFA CA 16 012
Funding Number: RFA CA 16 012
Agency: HHS-NIH11
Funding Amount: $150,000 |
Revisions to Add Provocative Question-Relevant Research to Active Research Projects (P01) Apply for RFA CA 16 013
Funding Number: RFA CA 16 013
Agency: HHS-NIH11
Funding Amount: $150,000 |
Revision Applications to R01 Awards for Research on the NCI's Provocative Questions (R01) Apply for RFA CA 16 010
Funding Number: RFA CA 16 010
Agency: HHS-NIH11
Funding Amount: $150,000 |
Role of Astrocytes and Astrocytic Networks in Drug Abuse (R01) Apply for PA 16 144
Funding Number: PA 16 144
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Apply for PA 16 146
Funding Number: PA 16 146
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Role of Astrocytes and Astrocytic Networks in Drug Abuse (R21) Apply for PA 16 145
Funding Number: PA 16 145
Agency: HHS-NIH11
Funding Amount: $200,000 |
Population Health Interventions: Integrating Individual and Group Level Evidence (R21) Apply for PA 16 147
Funding Number: PA 16 147
Agency: HHS-NIH11
Funding Amount: $200,000 |
Research Centers for Barretts Esophagus Translational Research Network (BETRNet)(U54) Apply for RFA CA 16 006
Funding Number: RFA CA 16 006
Agency: HHS-NIH11
Funding Amount: $900,000 |
Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25) Apply for PAR 16 139
Funding Number: PAR 16 139
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Coordinating Center for Barrett's Esophagus Translational Research Network (BETRNet)(U24) Apply for RFA CA 16 007
Funding Number: RFA CA 16 007
Agency: HHS-NIH11
Funding Amount: $250,000 |
The Early Detection Research Network: Biomarker Developmental Laboratories (U01) Apply for RFA CA 16 009
Funding Number: RFA CA 16 009
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25) Apply for PAR 16 138
Funding Number: PAR 16 138
Agency: HHS-NIH11
Funding Amount: $300,000 |
Emerging Questions in Cancer Systems Biology (U01) Apply for PAR 16 131
Funding Number: PAR 16 131
Agency: HHS-NIH11
Funding Amount: Case Dependent |
The Application of Big Data Analytics to Drug Abuse Research (R01) Apply for PA 16 119
Funding Number: PA 16 119
Agency: HHS-NIH11
Funding Amount: Case Dependent |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01) Apply for PAR 16 122
Funding Number: PAR 16 122
Agency: HHS-NIH11
Funding Amount: Case Dependent |
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) Apply for RFA DA 17 015
Funding Number: RFA DA 17 015
Agency: HHS-NIH11
Funding Amount: $1,000,000 |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21) Apply for PAR 16 123
Funding Number: PAR 16 123
Agency: HHS-NIH11
Funding Amount: $200,000 |
